---
title: "Taltz (ixekizumab), all indications: Pharmacology questions"
description: "Pharmacology questions on Taltz (ixekizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Mechanism, Pharmacokinetics, and Components. Questions: What class of drug is Taltz? How does Taltz work (mechanism of action)? How is Taltz metabolized? Does body weight affect Taltz levels? 1 further question follow. 5 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/taltz/pharmacology"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Taltz (ixekizumab), all indications: Pharmacology questions

Manufacturer: Eli Lilly and Company  
Prescribing information: [Taltz](https://uspl.lilly.com/taltz/taltz.html#pi)  
Indication pages: [Plaque psoriasis](https://www.evicenter.com/medical-information/taltz--plaque-psoriasis)

## Mechanism

<a id="taltz-drug-class"></a>

### What class of drug is Taltz?

> “TALTZ® is a humanized interleukin-17A antagonist”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=TALTZ%C2%AE%20is%20a%20humanized%20interleukin%2D17A%20antagonist)

<a id="taltz-mechanism"></a>

### How does Taltz work (mechanism of action)?

> “Ixekizumab is a humanized IgG4 monoclonal antibody that selectively binds with the interleukin 17A (IL-17A) cytokine and inhibits its interaction with the IL-17 receptor. IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses. Ixekizumab inhibits the release of proinflammatory cytokines and chemokines.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=Ixekizumab%20is%20a%20humanized%20IgG4,of%20proinflammatory%20cytokines%20and%20chemokines.)

> “IL-17A has been implicated in the pathogenesis of psoriasis”

Source: [TALTZ: Mechanism of Action | IL-17A & IgG4, captured 2026-11-14](https://taltz.lilly.com/hcp/moa-il17a-igg4#:~:text=IL%2D17A%20has%20been%20implicated%20in%20the%20pathogenesis%20of%20psoriasis)

> “The relationship between the mechanism of action and clinical outcomes has not been determined.”

Source: [TALTZ: Mechanism of Action | IL-17A & IgG4, captured 2026-11-14](https://taltz.lilly.com/hcp/moa-il17a-igg4#:~:text=The%20relationship%20between%20the%20mechanism,outcomes%20has%20not%20been%20determined.)

## Pharmacokinetics

<a id="taltz-metabolism"></a>

### How is Taltz metabolized?

> “The metabolic pathway of ixekizumab has not been characterized. As a humanized IgG4 monoclonal antibody ixekizumab is expected to be degraded into small peptides and amino acids via catabolic pathways in the same manner as endogenous IgG.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=The%20metabolic%20pathway%20of%20ixekizumab,same%20manner%20as%20endogenous%20IgG.)

<a id="taltz-body-weight"></a>

### Does body weight affect Taltz levels?

> “Ixekizumab clearance and volume of distribution increase as body weight increases.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=Ixekizumab%20clearance%20and%20volume%20of%20distribution%20increase%20as%20body%20weight%20increases.)

## Components

<a id="taltz-inactive-ingredients"></a>

### What are the inactive ingredients in Taltz?

> “Each TALTZ 80 mg/mL single-dose autoinjector or TALTZ 80 mg/mL single-dose prefilled syringe is composed of ixekizumab (80 mg); Polysorbate 80, USP (0.3 mg); Sucrose, USP (80 mg); and Water for Injection, USP. Sodium Hydroxide, USP-NF, may have been added to adjust pH. The TALTZ solution has a pH of 5.2 –  6.2.
>
> Each TALTZ 40 mg/0.5 mL single-dose prefilled syringe is composed of ixekizumab (40 mg); Polysorbate 80, USP (0.15 mg); Sucrose, USP (40 mg); and Water for Injection, USP. Sodium Hydroxide, USP-NF, may have been added to adjust pH. The TALTZ solution has a pH of 5.2 –  6.2.
>
> Each TALTZ 20 mg/0.25 mL single-dose prefilled syringe is composed of ixekizumab (20 mg); Polysorbate 80, USP (0.08 mg); Sucrose, USP (20 mg); and Water for Injection, USP. Sodium Hydroxide, USP-NF, may have been added to adjust pH. The TALTZ solution has a pH of 5.2 –  6.2.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=Each%20TALTZ%2080%20mg%2FmL%20single%2Ddose,The%20TALTZ%20solution%20has%20a%20pH%20of%205.2%20%E2%80%93%206.2.)

## Related pages
- [Medical information: Taltz (ixekizumab): All indications](https://www.evicenter.com/medical-information/taltz)
- [Indication](https://www.evicenter.com/medical-information/taltz/indication)
- [Safety](https://www.evicenter.com/medical-information/taltz/safety)
- [Specific populations](https://www.evicenter.com/medical-information/taltz/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/taltz/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/taltz/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/taltz/access-and-coverage)
